Disney embarks on new chapter as Josh D'Amaro takes over as CEO
CNBC
Bob Iger is stepping aside as Josh D'Amaro, who previously served as chairman of Disney's experiences division, takes over as CEO.
Disney is turning the page on a new chapter as Josh D'Amaro steps in as CEO of the media and theme park powerhouse.
D'Amaro most recently served as chairman of Disney Experiences, which includes the company's theme parks, cruise line, resorts and consumer products. He will officially succeed Bob Iger as chief executive during the company's annual shareholder meeting on Wednesday.
The longtime Disney executive takes over after a period of uncertainty for the century-old company — including a closely watched succession race and a recent reorganization and turnaround — that has left it with a mixed reception from Wall Street.
Some airlines are already raising fares after a historic surge in jet-fuel costs.
The Iran conflict is disrupting fertilizer shipments through the Strait of Hormuz, raising supply concerns and potentially increasing global food inflation.
JPMorgan's move shows that the biggest U.S. bank by assets wants to get ahead of potential turbulence involving private credit loans to software companies.
Ford CEO Jim Farley last month said diversifying Pro's revenue — specifically in software — is a crucial growth area for the company.
Home sales made a small gain to start the year, but higher mortgage rates now could throw cold water on the spring season.
The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms.
Lego on Tuesday reported a 12% jump in revenue for fiscal year 2025 and reported consumer sales that far outpace the broader toy industry.
Live Nation, which owns Ticketmaster, reached a settlement with the Department of Justice over antitrust concerns.
A growing number of consumers are seeking out third spaces and membership clubs surrounding wellness, to improve their health while also socializing.
Vinay Prasad is leaving his post as director of the Center for Biologics Evaluation and Research.
Investors are scrutinizing the prospects for some drugs in the pipeline following a string of recent rejections from the U.S. Food and Drug Administration.
A closely watched barometer for used vehicle pricing jumped last month as dealers sped to increase inventories amid optimism of a robust spring selling season.
Gap has been on a steady upswing of growth but saw worse than expected results during its holiday quarter after historic winter storms led to store closures.